Tunisia's Razi Centre for Alzheimer's disease has been accredited by the World Health Organization (WHO) as a collaborative partner, marking a significant milestone for the centre. The accreditation, which was achieved in 2026, makes the Razi Centre the first of its kind in Africa and the Arab world to receive such recognition. This development is a culmination of a decade-long collaboration between the centre and the WHO.
The Razi Centre, which was established in 2010, provides specialized services for patients with Alzheimer's disease, including a dedicated clinic and a day-care unit that can accommodate up to five patients per day. The centre also has sections dedicated to research and training medical professionals. Currently, the centre is caring for around 9,000 patients and has admitted over 800 cases to its day-care unit.
According to Dr. Riadh Quowider, head of the neurology department at Razi Hospital and director of the Alzheimer's centre, Tunisia has a significant number of Alzheimer's patients, estimated to be between 50,000 and 70,000. The country has the highest life expectancy in Africa, which contributes to the increasing prevalence of the disease. However, Dr. Quowider noted that medical services and screening for the disease currently cover only 20% of the country's needs.
Dr. Quowider highlighted that certain factors, such as intermarriage, increase the risk of developing Alzheimer's disease at an early age. He also warned that other risk factors, including heart disease, diabetes, high blood pressure, and early cessation of education, can exacerbate the condition. To mitigate the effects of the disease, Dr. Quowider recommended engaging in mentally stimulating activities, such as reading and cultural events.
The Razi Centre's accreditation is expected to enhance its capacity to provide training and research opportunities for medical professionals. Dr. Quowider emphasized the need for the centre to be equipped with the necessary resources to cater to the growing number of patients. He also called for the centre to be replicated in other parts of the country to ensure that patients have access to specialized care.
Dr. Quowider urged the government to include Alzheimer's disease in the list of chronic conditions covered by the National Health Insurance Fund. He noted that the monthly cost of caring for a patient with Alzheimer's disease exceeds twice the minimum guaranteed wage, placing a significant burden on families.
The accreditation of the Razi Centre is a significant step towards addressing the growing burden of Alzheimer's disease in Tunisia. With the centre's expanded capacity and resources, it is expected to play a more significant role in providing specialized care and services to patients with Alzheimer's disease.
Key points
- The Razi Centre's accreditation by the WHO is a significant milestone in its development as a centre of excellence for Alzheimer's disease care and research in Africa and the Arab world.
